Carl L. Pierson

Pharmacology, Toxicology and Pharmaceutics · Life Sciences

24h-index2.6kcitations53works0.02yr avg
OpenAlex↗Google Scholar↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Advancements in Transdermal Drug Delivery(11), Bacterial Identification and Susceptibility Testing(11), Antibiotics Pharmacokinetics and Efficacy(9), Diphtheria, Corynebacterium, and Tetanus(8), Dermatology and Skin Diseases(6)

Publications53 total

The Politics of Coaching
2011
Lessons Learned from the Anaerobe Survey: Historical Perspective and Review of the Most Recent Data (2005–2007)
Clinical Infectious Diseases·2010· 177 citedOpen Access
Clinical Correlation of the CLSI Susceptibility Breakpoint for Piperacillin- Tazobactam against Extended-Spectrum-β-Lactamase-Producing <i>Escherichia coli</i> and <i>Klebsiella</i> Species
Antimicrobial Agents and Chemotherapy·2006· 75 citedOpen Access
The effectiveness of standard povidone iodine surgical preparation in decontaminating external fixator components
Injury·2005· 12 cited
<i>Candida</i> Transmission and Sexual Behaviors as Risks for a Repeat Episode of <i>Candida</i> Vulvovaginitis
Journal of Women s Health·2003· 64 citedOpen Access
Correlates of Antibiotic-Resistant Group B Streptococcus Isolated From Pregnant Women
Obstetrics and Gynecology·2003· 14 cited
REVIEW OF FUNGAL ISOLATES OVER A SIX-YEAR PERIOD IN MEDICAL, SURGICAL AND TRAUMA BURN INTENSIVE CARE UNITS
Critical Care Medicine·2002
Possible Connection between a Widely Disseminated Conjugative Gentamicin Resistance (pMG1-Like) Plasmid and the Emergence of Vancomycin Resistance in <i>Enterococcus faecium</i>
Journal of Clinical Microbiology·2002· 98 citedOpen Access
Increased C5a receptor expression in sepsis
Journal of Clinical Investigation·2002· 152 cited
Increased C5a receptor expression in sepsis
Journal of Clinical Investigation·2002· 26 citedOpen Access
Increased C5a receptor expression in sepsis
Journal of Clinical Investigation·2002· 193 citedOpen Access
Frequency of Antibiotic Resistance among Group B<i>Streptococcus</i>Isolated from Healthy College Students
Clinical Infectious Diseases·2001· 24 citedOpen Access
Multicenter Survey of the Changing In Vitro Antimicrobial Susceptibilities of Clinical Isolates of <i>Bacteroides fragilis</i> Group, <i>Prevotella, Fusobacterium, Porphyromonas</i> , and <i>Peptostreptococcus</i> Species
Antimicrobial Agents and Chemotherapy·2001· 230 citedOpen Access
<b>Room I, 10/17/2000 9: 00 AM - 11: 00 AM (PS) Potency and Sterility of Anesthetic Drugs in an Obstetrical Setting</b> 
Anesthesiology·2000Open Access
Sexual Behaviors and Other Risk Factors for <i>Candida</i> Vulvovaginitis
Journal of Women s Health & Gender-Based Medicine·2000· 33 citedOpen Access
Multicenter Study of In Vitro Susceptibility of the <i>Bacteroides fragilis</i> Group, 1995 to 1996, with Comparison of Resistance Trends from 1990 to 1996
Antimicrobial Agents and Chemotherapy·1999· 107 citedOpen Access
Protective effects of C5a blockade in sepsis
Nature Medicine·1999· 404 cited
Use of the BacT/Alert Blood Culture System for Culture of Sterile Body Fluids Other than Blood
Journal of Clinical Microbiology·1998· 103 citedOpen Access
Frequent Resistance of Clinical Group B Streptococci Isolates to Clindamycin and Erythromycin
Obstetrics and Gynecology·1998· 17 cited
Ureaplasma urealyticum and chronic lung disease in very low birth weight infants during the exogenous surfactant era
The Pediatric Infectious Disease Journal·1998· 56 cited
page 1 of 3Next →

Frequent Co-authors

Gordon L. Flynn(11), William I. Higuchi(10), Norman F.H. Ho(10), Charanjit R. Behl(9), Tamie Kurihara(6), Vidya Sarma(4), Stephen G. Jenkins(4), Olivia G. Gatmaitan(4), Michael T. Barrett(4), Irving Feller(4), Mark D. Pearlman(4), Dennis R. Schaberg(4), Niels C. Riedemann(3), Thomas A. Neff(3), Ines J. Laudes(3), Katie A. Keller(3), Maciej M. Markiewski(3), Dimitrios C. Mastellos(3), Christoph W. Strey(3), John D. Lambris(3)